REPRESENTING THE PROFESSION THAT IMPACTS INDIVIDUAL LIVES AND COMMUNITIES
With
Michelle Oliver,
Chief Occupational Therapist
Occupational Therapy Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Adelaide | November 2025
Michelle Oliver is a highly experienced Occupational Therapist with nearly two decades of leadership and clinical expertise across the mental health, homelessness, and disability sectors. She holds a Master of Occupational Therapy from the University of South Australia and is a registered practitioner with AHPRA.
As the Chief Occupational Therapist at Occupational Therapy Australia (OTA), she leads national strategies to advance clinical excellence, drive workforce development, and champion sector-wide advocacy. Her leadership is crucial in shaping OTA’s influence within the health and disability systems.
Prior to her current role, Michelle served as the Principal Occupational Therapist at the Northern Adelaide Local Health Network, gaining a deep understanding of complex care environments. She is a recipient of a SA Health award for her commitment to consumer, carer, and community participation, and is a public advocate for evidence-based practice and high-quality care.
Source: Supplied
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Michelle Fenwick – Northern Health
The outskirts of Melbourne is experiencing significant population growth over the next 10 years and Northern Health has taken preemptive steps to ensure the supply of new talented healthcare staff as well as develop the culture of the workplace.
Michelle Fenwick, the Executive Director of Northern Health spoke with our reporter Anne Dao on the challenges of this urban growth over the past 3 years. By 2031 the region is expected to increase in population by 63%. Added to this is hiring and training the right workforce to align with the clinical care needs of people coming into the healthcare centres.
Culture is forming in a growing organisation with approximately 70% of staff having been at Northern Health less than 4 years. However there is opportunity for clinical staff to accelerate their career in such an environment
